India Morning Report: Weekend results from Cipla, Sun, vs the ultimate low for india’s production statistics

English: Generic finasteride 1mg tablets produ...

English: Generic finasteride 1mg tablets produced by Cipla India (Photo credit: Wikipedia)

 

July and August data that comes in the next few weeks could make the data for June and an almost negative IIp at the cus p of the biggest Rupee depreciation move since May 22 seem like next to nothing in comparison as Services crash in on the devolved growth mandate and curbs on non essential imports kill any remaining Hindu growth consumption in the Economy. Auto sales reports for July from Siam are as low as 131,000. Mauritius and pakistan could robably account for more cr registrations in a day but that is not rater affecting India inc.

 

The day has started well, with the obvious move back in Power NBFCs that could well merge into any revival of demand even as investment lags in corporate India have no end in sight. The revival of demand in such services could lead the way back to growing inventories , before they become a hangman’s noose around dealerships and the robust credit is used to demand off take back to a positive IIP. Today’s IIP reports and Q2’s first GDP estimates next month could thus see their worst data to come . Cipla’s results for example showed a 17% domestic sector growth, a continuing island where branded goods in both FMCG and Pharma will continue winning share at the expense of the unorganized market in sch a slowdown and Corporate India and Banks could easily maintain a non negative topline in the September quarter

 

Hero Moto is already responding to the covering rally as if its worst is over but then that is just a n ver motivate d market looking for trading gains as sBI results bringing in the last wreath for this quarter’s rituals on a continuing mourning for unreported asset losses being absorbed into the system even as the banking system gets ready for new stresses on asset quality as interest rates rise even before the coming injections of liquidity once the rupee stabilizes, but Corporate India performance and the continuing unique growth measures of India ensuring that things do not continue n the worse vein but grow back a clip from here even bringing back investments as Savings and investments have both been cut to the bone.

 

Jyothy Labs reports another big jump in profits to 287 mln after a` 4920 mln profits from Cipla even at a bare 25% EBITDA shining as Sun Pharma’s EBITDA after a bad quarter is still a giant 44% on almost a $1 Bln in Sales but needs to be penalized for the ` 3000 mln loss this quarter from the settlement

 

 

 

Advertisements

3 thoughts on “India Morning Report: Weekend results from Cipla, Sun, vs the ultimate low for india’s production statistics

  1. Pingback: India Morning Report: State Bank of India results scare, IIP for June -3%, $12.27 Bln Deficit | The India Investment Post (earlier india.advantages.us)

  2. Pingback: It’s Monday Again: Cancer Pharma M&A, Luxe retailers Sales reports and a higher GDP clip | The Banking and Strategy Initiative

  3. Pingback: India Morning Report : Rally snarled by a lack of fundamental strength (seen earlier) | The India Investment Post (earlier india.advantages.us)

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s